Evidence map›Paper›PMID 32073221›Full record

ArticlePhysiological reports2020

The acute effects of growth hormone in adipose tissue is associated with suppression of antilipolytic signals.

Katrine L Høyer, Morten L Høgild, Edward O List, Kevin Y Lee, Emily Kissinger, Rita Sharma, Nils Erik Magnusson, Vishwajeet Puri, John J Kopchick, Jens O L Jørgensen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Recent advances on the role of G0S2.Discover oncology · 2025
    Review
  6. Article
  7. Damaging missense variants inCell genomics · 2022
    Article
  8. Associations ofAdipocyte · 2022
    Article
  9. Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.The Journal of clinical endocrinology and metabolism · 2022 · on this map
    Review
  10. Growth Hormone and Aging: New Findings.The world journal of men's health · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Katrine L HøyerMedical Research Laboratory, Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Morten L HøgildMedical Research Laboratory, Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Edward O ListThe Edison Biotechnology Institute, Athens, OH, USA.
Kevin Y LeeHeritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.
Emily KissingerHeritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.
Rita SharmaHeritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.
Nils Erik MagnussonMedical Research Laboratory, Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Vishwajeet PuriHeritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA.
John J KopchickThe Edison Biotechnology Institute, Athens, OH, USA.
Jens O L JørgensenMedical Research Laboratory, Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-7408-1526
Niels JessenDepartment of Clinical Pharmacology, University of Aarhus, Aarhus, Denmark.ORCID 0000-0001-5613-7274
Aarhus University · DKOhio University · USOhio University Lancaster · USSteno Diabetes Centers · DK

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
NIA NIH HHS R01 AG059779
6 · The paper itself

Abstract

aimSince GH stimulates lipolysis in vivo after a 2-hr lag phase, we studied whether this involves GH signaling and gene expression in adipose tissue (AT).

methodsHuman subjects (n = 9) each underwent intravenous exposure to GH versus saline with measurement of serum FFA, and GH signaling, gene array, and protein in AT biopsies after 30-120 min. Human data were corroborated in adipose-specific GH receptor knockout (FaGHRKO) mice versus wild-type mice. Expression of candidate genes identified in the array were investigated in 3T3-L1 adipocytes.

resultsGH increased serum FFA and AT phosphorylation of STAT5b in human subjects. This was replicated in wild-type mice, but not in FaGHRKO mice. The array identified 53 GH-regulated genes, and Ingenuity Pathway analysis showed downregulation of PDE3b, an insulin-dependent antilipolytic signal, upregulation of PTEN that inhibits insulin-dependent antilipolysis, and downregulation of G0S2 and RASD1, both encoding antilipolytic proteins. This was confirmed in 3T3-L1 adipocytes, except for PDE3B, including reciprocal effects of GH and insulin on mRNA expression of PTEN, RASD1, and G0S2.

conclusion(a) GH directly stimulates AT lipolysis in a GHR-dependent manner, (b) this involves suppression of antilipolytic signals at the level of gene expression, (c) the underlying GH signaling pathways remain to be defined.

Indexed as

Lipolysis3T3 CellsAdipose TissueAdultAnimalsCyclic Nucleotide Phosphodiesterases, Type 3Fatty Acids, NonesterifiedFemaleHuman Growth HormoneHumansInsulinMaleMiceMiddle AgedPTEN Phosphohydrolaseras ProteinsCyclic Nucleotide Phosphodiesterases, Type 3Fatty Acids, NonesterifiedHuman Growth HormoneInsulinPDE3B protein, humanPTEN PhosphohydrolasePTEN protein, humanRASD1 protein, humanras ProteinsReceptors, SomatotropinSTAT5B protein, humanSTAT5 Transcription Factorclinical studiesfatty acid/metabolismgene expressiongrowth hormonehormoneslipase/hormone sensitive

Identifiers

PMID32073221
PMCPMC7029434
OpenAlexW3006306388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.